GlassScriptPhysician profile
Ahmareen Baten
NPI 1871836023
$1,670.25
in general payments reported to CMS, 2019-2025
18 companies · $809 in 2025
The $809 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.61 · 2023: $137 · 2024: $694 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.67 | 2022-2025 | Botox, Qulipta |
| Sk Life Science, INC. | $152.77 | 2024-2025 | |
| Pfizer INC. | $125.98 | 2024-2025 | |
| Livanova USA, INC. | $123.57 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $114.59 | 2023-2025 | Valtoco |
| Lilly USA, LLC | $113.62 | 2024-2025 | Amyvid, Kisunla, Reyvow |
| Ucb, INC. | $98.31 | 2023-2025 | Briviact, Nayzilam |
| Lundbeck LLC | $85.17 | 2024-2025 | Vyepti |
| Catalyst Pharmaceuticals, INC. | $80.69 | 2023-2024 | Fycompa |
| Eisai INC. | $47.20 | 2024 | |
| Aucta Pharmaceuticals, INC. | $43.90 | 2025 | Motpoly Xr |
| Biogen, INC. | $41.95 | 2024-2025 | Tysabri, Vumerity |
| Jazz Pharmaceuticals INC. | $38.70 | 2024 | |
| Acadia Pharmaceuticals INC | $37.63 | 2024-2025 | Daybue, Nuplazid |
| Janssen Biotech, INC. | $36.08 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Banner Life Sciences, LLC | $33.35 | 2024 | |
| Axsome Therapeutics, INC. | $32.39 | 2025 | Symbravo |
| Genentech USA, INC. | $19.68 | 2025 | Ocrevus Zunovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmareen Baten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.